A genome-wide association study of inflammatory biomarker changes in response to fenofibrate treatment in the Genetics of Lipid Lowering Drug and Diet Network (GOLDN)

OBJECTIVE: Despite evidence in support of anti-inflammatory and triglyceride-lowering effects of fenofibrate, little is known about genetic determinants of the observed heterogeneity in treatment response. This study provides the first genome-wide examination of fenofibrate effects on systemic infla...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Aslibekyan, Stella, Kabagambe, Edmond K., Irvin, Marguerite R., Straka, Robert J., Borecki, Ingrid B., Tiwari, Hemant K., Tsai, Michael Y., Hopkins, Paul N., Shen, Jian, Lai, Chao-Qiang, Ordovas, Jose M., Arnett, Donna K.
Formato: Artigo
Idioma:Inglês
Publicado: 2012
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3275691/
https://ncbi.nlm.nih.gov/pubmed/22228203
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/FPC.0b013e32834fdd41
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares